Company / Operating Cash Flow per Share
HERON THERAPEUTICS, INC. /DE/ Operating Cash Flow per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1995.32
FY2017
5-year range
-$1995.32 / -$1.67
FY2016-FY2017
Trend
-119410.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-1995.32 in FY2017.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, operating cash flow per share decreased 119410.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$1995.32 | -119410.3% |
| FY2016 | -$1.67 | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026